Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Goldberg

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
New Jersey Medicine : the Journal of the Medical Society of New Jersey|January 1, 1995
Adrenal pseudocyst: report of two casesK C Bapat, S M Awad, J S Cooperman, et al.
Bone Marrow Transplantation|March 1, 1997
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplantI Redei, K F Mangan, P L Ming, et al.
The American Journal of Cardiology|April 6, 1999
Intravenous three-dimensional coronary angiography using contrast enhanced electron beam computed tomographyM J Budoff, R J Oudiz, C P Zalace, et al.
The Journal of Invasive Cardiology|December 9, 1994
Clinical and angiographic outcome after Palmaz-Schatz stent implantation guided by intravascular ultrasoundP Hall, S Nakamura, L Maiello, et al.
Bone Marrow Transplantation|June 1, 1996
Factors associated with response to platelet transfusion following hematopoietic stem cell transplantationT R Klumpp, J H Herman, S Innis, et al.
Cytotherapy|May 25, 2002
Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancerR A Preti, H M Lazarus, J Winter, et al.
Transfusion|July 21, 1999
Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trialT R Klumpp, J H Herman, J P Gaughan, et al.
Leukemia|December 14, 2011
Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phaseF J Giles, H M Kantarjian, P D le Coutre, et al.
Bone Marrow Transplantation|September 6, 2001
A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantationA L Pecora, P Stiff, C F LeMaistre, et al.
Leukemia|October 4, 2012
Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndromeL Sokol, L Cripe, H Kantarjian, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
New Jersey Medicine : the Journal of the Medical Society of New Jersey|January 1, 1995
Adrenal pseudocyst: report of two casesK C Bapat, S M Awad, J S Cooperman, et al.
Bone Marrow Transplantation|March 1, 1997
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplantI Redei, K F Mangan, P L Ming, et al.
The American Journal of Cardiology|April 6, 1999
Intravenous three-dimensional coronary angiography using contrast enhanced electron beam computed tomographyM J Budoff, R J Oudiz, C P Zalace, et al.
The Journal of Invasive Cardiology|December 9, 1994
Clinical and angiographic outcome after Palmaz-Schatz stent implantation guided by intravascular ultrasoundP Hall, S Nakamura, L Maiello, et al.
Bone Marrow Transplantation|June 1, 1996
Factors associated with response to platelet transfusion following hematopoietic stem cell transplantationT R Klumpp, J H Herman, S Innis, et al.
Cytotherapy|May 25, 2002
Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancerR A Preti, H M Lazarus, J Winter, et al.
Transfusion|July 21, 1999
Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trialT R Klumpp, J H Herman, J P Gaughan, et al.
Leukemia|December 14, 2011
Nilotinib is effective in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blastic phaseF J Giles, H M Kantarjian, P D le Coutre, et al.
Bone Marrow Transplantation|September 6, 2001
A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantationA L Pecora, P Stiff, C F LeMaistre, et al.
Leukemia|October 4, 2012
Randomized, dose-escalation study of the p38α MAPK inhibitor SCIO-469 in patients with myelodysplastic syndromeL Sokol, L Cripe, H Kantarjian, et al.
Pageof 8